<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AJAC</journal-id><journal-title-group><journal-title>American Journal of Analytical Chemistry</journal-title></journal-title-group><issn pub-type="epub">2156-8251</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ajac.2013.43017</article-id><article-id pub-id-type="publisher-id">AJAC-29051</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Determination of Enantiomeric Composition of Substituted Tetrahydroisoquinolines Based on Derivatization with Menthyl Chloroformate
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>an</surname><given-names>Přech</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Václav</surname><given-names>Matoušek</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jiří</surname><given-names>Václavík</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jan</surname><given-names>Pecháček</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kamila</surname><given-names>Syslová</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Petr</surname><given-names>Šot</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jakub</surname><given-names>Januščák</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Beáta</surname><given-names>Vilhanová</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marek</surname><given-names>Kuzma</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Petr</surname><given-names>Kačer</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Organic Technology, Institute of Chemical Technology, Prague, Czech Republic</addr-line></aff><aff id="aff2"><addr-line>Laboratory of Molecular Structure Characterization, Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>petr.kacer@vscht.cz(PK)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>03</month><year>2013</year></pub-date><volume>04</volume><issue>03</issue><fpage>125</fpage><lpage>133</lpage><history><date date-type="received"><day>February</day>	<month>3,</month>	<year>2013</year></date><date date-type="rev-recd"><day>March</day>	<month>5,</month>	<year>2013</year>	</date><date date-type="accepted"><day>March</day>	<month>17,</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   A method for the analysis of the optical purity of a series of chiral substituted tetrahydroisoquinolines (THIQs) was developed. The method is based on pre-column derivatization of the analytes with the derivatization reagent (–)-(1R)-menthyl chloroformate. The derivatization reaction selectively gives diastereomeric carbamates that are resolvable on an achiral non-polar GC column. The developed technique covers variously substituted THIQs, which differ significantly in volatility, steric and electronic properties. In all cases, the resolution factors (R) exceeded the value of 1.5. The method represents a robust way of analysis of mixtures of THIQs, which are often present in various matrixes such as body fluids, tissues and reaction mixtures. 
 
</p></abstract><kwd-group><kwd>Tetrahydroisoquinolines; Enantiomeric Composition; Derivatization; Menthyl Chloroformate;  Gas Chromatography</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Substituted 1,2,3,4-tetrahydroisoquinolines (THIQs) are substances of both natural and synthetic origin. Their chiral N-heterocyclic scaffold is an integral part of all tetrahydroisoquinoline alkaloids. In a human organism, THIQs affect many physiological and pathological processes. Among the most important endogenously present THIQs are salsolinol (1-methyl-6,7-dihydroxy-THIQ, a catechol isoquinoline) and its derivatives (N-methyl-salsolinol, norsalsolinol, N-methyl-norsalsolinol), which are all products of reactions of dopamine and aldehydes (e.g. acetaldehyde) catalyzed by the enzyme salsolinol synthase [<xref ref-type="bibr" rid="scirp.29051-ref1">1</xref>]. Salsolinol has a physiological function in the organism (regulation of prolactin release, neuronal transmission in sympathetic ganglia, neurotransmission modulation, influence upon the central metabolism and motor activity) but at higher concentrations it causes neurodegenerative diseases such as Parkinson’s disease [<xref ref-type="bibr" rid="scirp.29051-ref2">2</xref>]. Higher concentration level of salsolinol has been detected during alcoholism in plasma or urine [<xref ref-type="bibr" rid="scirp.29051-ref3">3</xref>].</p><p>Additional examples of important THIQs include noscapine (a benzylisoquinoline alkaloid contained in the plants of the Papaveraceae family), which was used for its antitussive (cough-suppressing) effects, S-crypto-stylines (isolated from orchids of the genus Cryptostylis), salsoline (isolated e.g. from Corispermum leptopyrum L.) and tubocurarine (known as curare present in the bark of plants Chondrodendron tomentosum). Tubocurarine is a typical non-depolarizing neuromuscular-blocking drug causing the relaxation of skeletal muscles. Since the relaxation is of high importance in surgical procedures, the synthetic derivatives of tubocurarine are commonly used in anaesthesia [<xref ref-type="bibr" rid="scirp.29051-ref4">4</xref>]. Like tubocurarine, these compounds interact with the nicotinic acetylcholine receptors contained in the neuromuscular junction. Due to the optical preference of the receptors, which is very common in general [<xref ref-type="bibr" rid="scirp.29051-ref5">5</xref>], optically pure THIQs (i.e. single enantiomers that exhibit the desired effect) must be administered as the neuromuscular-blocking drugs.</p><p>The synthetic derivatives of tubocurarine such as mivacurium chloride and gantacurium chloride can be prepared via the asymmetric transfer hydrogenation (ATH) of prochiral substituted 3,4-dihydroisoquinolines (DHIQs) by using Noyori’s chiral half-sandwich catalysts [6-9]. It is important that a universal method for the determination of natural and synthetic THIQ derivatives be developed. Such a method would be capable of resolving individual R and S isomers of a wide range of substituted THIQs in various matrixes (reaction mixture, body fluids (plasma, cerebrospinal fluid and urine) and tissues (brain tissue)).</p><p>Nowadays, there are several different methods available for the analysis of substituted chiral THIQs. These methods typically employ gas chromatography coupled to mass spectrometry [10,11] and liquid chromatography with UV [12,13], fluorescent [<xref ref-type="bibr" rid="scirp.29051-ref14">14</xref>] or mass-spectrometric detection [15,16]. In cases when an achiral GC or LC column is used for the determination of enantiomeric excess, the mixture of enantiomers needs to be reacted with optically pure reagents prior to the analysis [17,18]. There are a number of agents available for pre-column derivatization, such as Mosher’s acid [19-21], camphanic acid [<xref ref-type="bibr" rid="scirp.29051-ref22">22</xref>], perfluoro-2-propoxypropionylchloride [<xref ref-type="bibr" rid="scirp.29051-ref11">11</xref>] and others. In all cases, resolvable diastereomers are formed in a ratio identical to that of original enantiomers. In the case of substituted THIQs, a GC with a chiral column often cannot be used owing to the high boiling point of these compounds and low stability of the column’s stationary phase. For some of 1-methyl and 1-phenyl THIQs, chiral LC methods with polysaccharide [<xref ref-type="bibr" rid="scirp.29051-ref12">12</xref>] or crown ether [<xref ref-type="bibr" rid="scirp.29051-ref13">13</xref>] stationary phase have been developed. Nonetheless, these methods are only applicable to a limited number of analytes due to considerably low resolution of peaks [<xref ref-type="bibr" rid="scirp.29051-ref13">13</xref>].</p><p>The determination of the optical purity (i.e. enantiomeric ratio or enantiomeric excess) of chiral THIQs plays an important role both in the pharmaceutical industry and medicinal diagnostics (e.g. Parkinson’s disease, predisposition to alcoholism). For that reason, it is highly desirable to develop a method capable of analysis of a wide spectrum of chiral substituted THIQs. In this regard, a suitable method appears to be that which is based on precolumn derivatization (where the reagent reacts with the nitrogen atom in the heterocycle) in a combination with high performance gas chromatography on an achiral column coupled with mass-spectrometric detection.</p></sec><sec id="s2"><title>2. Experimental</title><sec id="s2_1"><title>2.1. Chemicals</title><p>The following chemicals and reagents were of comercial origin: (–)-(1R)-menthyl chloroformate (99%; ee = 99.9%); triethylamine (99.5%) (Sigma-Aldrich, Germany); sodium borohydride (97%) (CMS Chemicals, Slovakia); acetonitrile (99.5%), methanol (99.5%); diethyl ether (99%), anhydrous potassium carbonate (p.a.), sodium hydroxide (98%) (Penta, Czech Republic).</p><p>Substituted chiral THIQs 1-methyl-THIQ (1); 6-methoxy-1-methyl-THIQ (2); 7-methoxy-1-methyl-THIQ (3); 6,7-dimethoxy-1-methyl-THIQ (4); 1-phenyl-THIQ (5); 1-(4-methylphenyl)-THIQ (6); 1-(4-methoxyphenyl)-THIQ (7) and 1-[4-(trifluoromethyl)phenyl]-THIQ (8) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) were prepared in both racemic and enantioenriched form, the former by non-stereoselective sodium tetrahydridoborate reduction, the latter by ATH of corresponding DHIQs according to Noyori protocol [<xref ref-type="bibr" rid="scirp.29051-ref6">6</xref>]. Substituted DHIQs were synthesized by Bischler-Napieralski cyclodehydration from corresponding phenethylamides according to our previously reported procedure [<xref ref-type="bibr" rid="scirp.29051-ref23">23</xref>].</p></sec><sec id="s2_2"><title>2.2. Instrumentation</title><p>GC analysis was carried out on a Varian CP 3800 equipped with a flame-ionization detector (Varian FID 11), Varian 1177 injector, Varian VF-1 capillary column (60 m &#215; 0.25 mm &#215; 0.25 &#181;m) and Varian Combi/Liquid PAL system autosampler. The oven temperature program is described in <xref ref-type="table" rid="table1">Table 1</xref>. The flow of carrier gas (nitrogen, 99.99%) was 0.5 mL/min, the temperature of injector was 300˚C, the split ratio was 1:25 and the injection volume was 1 μL. The temperature of detector was 250˚C.</p><p>Structure determination of derivatized THIQs was performed using a GC-MS system consisting of Varian CP 3800 coupled to a Saturn 2000 mass spectrometer equipped with electron impact ionization and an ion trap.</p><p>The system was equipped with VF-1ms capillary column (60 m &#215; 0.25 mm &#215; 0.25 &#181;m). The carrier gas was helium (99.9999%). The GC method was identical to the one described above for GC analyses. The temperatures of transfer line and ion trap were 180˚C and 150˚C, respectively. Standard electron impact conditions (70 eV) were used. The solvent delay was set to 10 minutes.</p></sec><sec id="s2_3"><title>2.3. Derivatization Procedure</title><p>Racemic or enantiomerically enriched THIQ (typically 3 mg; 0.01 - 0.02 mmol) was dissolved in acetonitrile (1 mL) and triethylamine (TEA) (20 mL, 0.14 mmol) was added followed by (–)-(1R)-menthyl chloroformate (10 mL, 0.03 mmol). The mixture was reacted for 10 minutes at room temperature (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and directly analyzed on GC.</p><p>For samples containing 3 - 6 mg of the THIQs, the amounts of the reagents were doubled.</p><p><xref ref-type="table" rid="table1">Table 1</xref>. Temperature program of the column.</p><p><img src="3-2200516\5acaa38c-bfa1-4496-855b-2dcafc1ad68f.jpg" /></p></sec><sec id="s2_4"><title>2.4. Calculations</title><p>Separation parameters in the optimization of the chromatographic conditions and enantiomeric excess were defined as follows:</p><disp-formula id="scirp.29051-formula77926"><label>(1)</label><graphic position="anchor" xlink:href="3-2200516\aa603d9f-b5a4-4003-beb2-e9222358a08d.jpg"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.29051-formula77927"><label>(2)</label><graphic position="anchor" xlink:href="3-2200516\d3440567-b583-4e9f-b13e-55dfb465a715.jpg"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.29051-formula77928"><label>(3)</label><graphic position="anchor" xlink:href="3-2200516\fc7aa26b-010c-4aa8-b98f-389b67712ddb.jpg"  xlink:type="simple"/></disp-formula><p>Symbols R, α and ee represent the resolution factor, selectivity factor and enantiomeric excess, respectively. Symbols t, w and c are retention time, peak width at the baseline and concentration of the diastereomer. The suffixes 1 and 2 correspond to the first and second detected diastereomer. The suffixes maj and min refer to the major or minor diastereomer in a non-racemic mixture. As the concentrations of the enantiomers were determined always in one analysis, they stood as internal standards to each other.</p></sec><sec id="s2_5"><title>2.5. Method Performance</title><p>The following parameters were determined during the method validation: limit of detection (LOD), limit of quantification (LOQ), linear range, accuracy and precision.</p><p>The calibration lines were evaluated under optimal chromatographic conditions by injection of 5 standard solutions of derivatized racemic THIQs and peak area measurement. Calibration equations, correlation coefficients (R2) and linear ranges were determined.</p><p>Detection and quantification limits were estimated by analyzing racemic standard solutions at low concentrations. LODs and LOQs were determined as the lowest concentration of the analyte that produced chromatographic peak at a signal to noise ratio of 3 and 10, respectively.</p><p>The accuracy and precision of the method was established through the measurements of enantiomer retention times and peak areas using standard solutions of 1 mg/mL. Precision is expressed as the repeatability (RSD, %) of four consecutive injections. For inter-day precision and carbamate stability, derivatized samples were analyzed daily over a 3-day period.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><p>The chromatogram of derivatized THIQs (<xref ref-type="fig" rid="fig3">Figure 3</xref>) contained no signals of non-derivatized amines, indicating 100% conversion to corresponding carbamates. The structure of the carbamates was confirmed by GC-MS analysis (<xref ref-type="fig" rid="fig4">Figure 4</xref>). To the best of our knowledge, the spectra of these compounds have not been published before.</p><p>The ee value for compound 4 agreed with the one reported previously [<xref ref-type="bibr" rid="scirp.29051-ref6">6</xref>] by using chiral HPLC column. Compounds 1, 4 and 5 were also analyzed using a chiral HPLC method described in [<xref ref-type="bibr" rid="scirp.29051-ref24">24</xref>], obtaining ee values identical to those obtained by GC analysis of derivatized THIQs.</p><p>Retention times of the carbamates are summarized in <xref ref-type="table" rid="table2">Table 2</xref>, together with their resolution and separation factors determined at the concentrations of THIQs c = 0.5 mg/mL. The peaks within 10 - 30 min represent the unreacted excess of (–)-(1R)-menthyl chloroformate (t = 27.12 min) and products of its thermal decomposition during evaporation of the sample (mainly 2-(prop-2-yl)- 5-methylcyclohexanol, according to the GC-MS analysis; t = 14.62 min).</p><p><xref ref-type="table" rid="table2">Table 2</xref>. Retention times, resolution and separation factors of the derivatized THIQs.</p><p><img src="3-2200516\87daa0c5-f4d0-4625-9462-9e096baf07bf.jpg" /></p><p><sup>a</sup>Retention times of the corresponding carbamates.</p><sec id="s3_1"><title>3.1. Robustness of the Derivatization Method</title><p>No remarkable loss of response or change in the ratio of diastereomeric peaks was observed during a 5-day period. Experiments using less than 1 molar eq of (–)-(1R)-menthyl chloroformate for the derivatization of racemate did not confirm any preferential derivatization of particular enantiomer (i.e. chiral discrimination). It was possible to derivatize THIQs even in large excess of competing nucleophiles (20 molar eq of ethanol or 20 molar eq of morpholine) indicating robustness of this methodology. High separation efficiency of the GC column even allowed us to determine the enantiomeric composition of two regioisomeric THIQs 2 and 3 present simultaneously in a mixture (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Resolution factor of the second diastereomeric peak of 3 and the first diastereomeric peak of 2 was R = 1.22.</p></sec><sec id="s3_2"><title>3.2. Main EI Fragmentation Routes</title><p>The mass spectra of diastereomeric carbamates are presented in <xref ref-type="fig" rid="fig4">Figure 4</xref>. The molecular ion peaks were either missing (carbamates corresponding to 1, 2, 3, 4 and 8), or were present with weak intensity (carbamates corresponding to 5, 6 and 7). The main features of all spectra were ions of m/z = M-138, being usually the base peak (BP), or having intensities similar to the BP. Those signals represented the neutral loss of p-isopropylmethyl-cyclohexene—a fragment of the menthyl moiety. The heaviest ions for 1-methyl substituted THIQ carbamates were signals m/z = M-15, representing the loss of a methyl radical. The methyl substituent was lost from position 1 in the THIQ skeleton because similar signals in the spectra of 1-phenyl THIQ carbamates were missing. The heaviest ions in the spectra of 1-phenyl THIQ carbamates were the molecular ions with low intensity and mentioned m/z = M-138 radical. The fragmentation patterns for both 1- methyl-THIQ carbamates and 1-phenyl-THIQ carbamates are summarized in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</p><p>The THIQ skeleton appears to be the most stable fragment of the molecule as evidenced by lighter signals in the spectra, which represents this part of the molecule losing other substituents. For instance, m/z = M-183 represents the loss of entire menthyl-formate fragment (carbamates corresponding to 5, 6, 7 and 8) and m/z = 176</p><p>(carbamates corresponding to 1, 5, 6, 7 and 8) represents the loss of p-isopropyl(methyl)cyclohexene together with the substituent in position 1 of THIQ.</p><p>The lightest considerable signals were m/z = 132 (carbamates corresponding to 1, 5, 6, 7 and 8), m/z = 162 (carbamates corresponding to 2 and 4), and m/z = 192 (carbamate corresponding to 4), which belong to discrete THIQ skeleton bearing only substituents in positions 6 and 7, if applicable (molecules 2 - 4). Signals below m/z = 100 represent a mixture of small fragments of the molecule and have generally low intensity, e.g. fragment ions of the THIQ skeleton could be found (m/z = 91, 83, 55 and 39).</p></sec><sec id="s3_3"><title>3.3. Method Validation</title><p>The method performance was evaluated based on the following analytical parameters: LOQ, LOD, linear range accuracy and precision. LOQ and LOD values were estimated as described in Section 2.5 by injection of diluted samples with defined concentration of starting THIQs. The diluted samples were derivatized with standard amounts of reagents before the analysis.</p><p>The determination of the linearity of the instrumental response was based on peak area. Calibration standards of racemic THIQs were prepared in acetonitrile at concentrations ranging from 10 μg/mL (average LOQ for the THIQs, see <xref ref-type="table" rid="table3">Table 3</xref>) to 5 mg/mL. Linear regression ana</p><p><xref ref-type="table" rid="table3">Table 3</xref>. Validation parameters of the method.</p><p><img src="3-2200516\0e865596-b524-471a-b4af-2300cf9d6f29.jpg" /></p><p><sup>a</sup>Calibration curve as the response of the detector (y) dependent on the concentration (x [mg/ml]) of the sample before derivatization. <sup>b</sup>Correlation coefficient of the calibration curve. <sup>c</sup>Repeatability determined as relative standard deviation n = 4; c = 100 μg/mL. <sup>d</sup>Inter-day stability determined as relative standard deviation n = 3; c = 20 μg/mL.</p><p>lysis was applied to plots of peak area vs concentration using the least-square method. Excellent linearity was observed at concentrations within the tested interval. The correlation coefficients (r<sup>2</sup>) were higher than 0.99 for all the compounds.</p></sec><sec id="s3_4"><title>3.4. Example of Application</title><p>The ATH of cyclic imines has become a well-established route toward the production of optically enriched tertiary amines [<xref ref-type="bibr" rid="scirp.29051-ref25">25</xref>] and therefore a method for the determination of ee is highly desirable in this field. We carried out a kinetic experiment consisting in the ATH of a prochiral DHIQ to a THIQ catalyzed by RuCl(η<sup>6</sup>-p-cymene)[(S,S)- TsDPEN] (TsDPEN = N-p-tosyl-1,2-diphenylethylene-1, 2-diamine) [<xref ref-type="bibr" rid="scirp.29051-ref6">6</xref>]. The developed method was successfully applied in the determination of the product’s ee.</p><p><xref ref-type="fig" rid="fig6">Figure 6</xref> represents a typical conversion and ee profile of the ATH of 1-methyl-3,4-dihydroisoquinoline (1-MeDHIQ) to 1 in acetonitrile at 30˚C and 1-Me-DHIQ/ catalyst molar ratio (S/C) of 100. The azeotropic mixture of formic acid and triethylamine (5:2 mol/mol) was used as a hydrogen source and the initial concentration of 1- Me-DHIQ was 0.344 mol/L. The ee (81.8% &#177; 0.34%) remained constant during the reaction.</p></sec></sec></body><back><ref-list><title>References</title><ref id="scirp.29051-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">W. Maruyama, G. Sobue, K. Matsubara, Y. Hashizume, P. Dostert and M. Naoi, “A Dopaminergic Neurotoxin, 1(R), 2(N)-Dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-Methyl(R)salsolinol, and Its Oxidation Product, 1, 2(N)-Dimethyl-6,7-dihydroxyisoquinolinium Ion, Accumulate in the Nigro-Striatal System of the Human Brain,” Neuroscience Letters, Vol. 223, No. 1, 1997, pp. 61-64.  
doi:10.1016/S0304-3940(97)13389-4</mixed-citation></ref><ref id="scirp.29051-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">W. Zhu, D. Wang, J. Zheng, A. Yarui, Q. Wang, W. Zhang, L. Jin, H. Gao and L. Lin, “Effect of (R)-Salsolinol and N-Methyl-(R)-Salsolinol on the Balance Impairment between Dopamine and Acetylcholine in Rat Brain: Involvement in Pathogenesis of Parkinson Disease,” Clinical Chemistry, Vol. 54, No. 4, 2008, pp. 705-712. 
doi:10.1373/clinchem.2007.097725</mixed-citation></ref><ref id="scirp.29051-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">H. Haber, A. Winkler, I. Putscher, P. Henklein, I. Baeger, M. Georgi and M. F. Melzig, “Plasma and Urine Salsolinol in Humans: Effect of Acute Ethanol Intake on the Enantiomeric Composition of Salsolinol,” Alcoholism: Clinical and Experimental Research, Vol. 20, No. 1, 1996, pp. 87-92. doi:10.1111/j.1530-0277.1996.tb01049.x</mixed-citation></ref><ref id="scirp.29051-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">H. Ihmsen, J. Schmidt, H. Schwilden, H. J. Schmitt and T. Muenster, “Influence of Disease Progression on the Neuromuscular Blocking Effect of Mivacurium in Children and Adolescents with Duchenne Muscular Dystrophy,” Anesthesiology, Vol. 110, No. 5, 2009, pp. 1016-1019. 
doi:10.1097/ALN.0b013e31819daf31</mixed-citation></ref><ref id="scirp.29051-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">J. Caldwell, “The Importance of Stereochemistry in Drug Action and Disposition,” Journal of Clinical Pharmacology, Vol. 32, No. 10, 1992, pp. 925-929.</mixed-citation></ref><ref id="scirp.29051-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">N. Uematsu, A. Fujii, S. Hashiguchi, T. Ikariya and R. Noyori, “Asymmetric Transfer Hydrogenation of Imines,” Journal of American Chemical Society, Vol. 118, No. 20, 1996, pp. 4916-4917. doi:10.1021/ja960364k</mixed-citation></ref><ref id="scirp.29051-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">V. Samano, J. A. Ray, J. B. Thompson, R. A. Mook, D. K. Jung, C. S. Koble, M. T. Martin, E. C. Bigham, C. S. Regitz, P. L. Feldman and E. E. Boros, “Synthesis of Ultra-Short-Acting Neuromuscular Blocker GW 0430: A Remarkably Stereoand Regioselective Synthesis of Tetrahydroisoquinolinium Chlorofumarates,” Organic Letters, Vol. 1, No. 12, 1999, pp. 1993-1996. 
doi:10.1021/ol9911573</mixed-citation></ref><ref id="scirp.29051-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">M. Ru?i?, A. Pe?avar, D. Prudi?, D. Kralj, C. Scriban and A. Zanotti-Gerosa, “The Development of an Asymmetric Hydrogenation Process for the Preparation of Solifenacin,” Organic Process Research &amp; Development, Vol. 16, No. 7, 2012, pp. 1293-1300. doi:10.1021/op3000543 </mixed-citation></ref><ref id="scirp.29051-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">B. Vilhanová, V. Matou?ek, J. Václavík, K. Syslová, J. P?ech, J. Pechá?ek, P. ?ot, J. Janu??ák, J. Toman, J. Zápal, M. Kuzma and P. Ka?er, “Two Optimized Synthetic Pathways toward a Chiral Precursor of Mivacurium Chloride and Other Skeletal Muscle Relaxants,” Tetrahedron: Asymmetry, Vol. 24, No. 1, 2013, pp. 50-55. 
doi:10.1016/j.tetasy.2012.11.012 </mixed-citation></ref><ref id="scirp.29051-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">M. Kajita, T. Niwa, M. Fujisaki, M. Ueki, K. Niimura, M. Sato, K. Egami, M. Naoi, M. Yoshida and T. Nagatsu, “Detection of 1-Phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-Phenyl-1,2,3,4-tetrahydroisoquinoline in Human Brain by Gas Chromatography-Tandem Mass Spectrometry,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 669, No. 2, 1995, pp. 345-351. doi:10.1016/0378-4347(95)00106-S</mixed-citation></ref><ref id="scirp.29051-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Y. Makino, Y. Tasaki, S. Ohta and M. Hirobe, “Confirmation of the Enantiomers of 1-Methyl-1,2,3,4-tetrahydroisoquinoline in the Mouse Brain and Foods Applying Gas Chromatography/Mass Spectrometry with Negative Ion Chemical Ionization,” Biological Mass Spectrometry, Vol. 19, No. 7, 1990, pp. 415-419. 
doi:10.1002/bms.1200190706</mixed-citation></ref><ref id="scirp.29051-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">H. Ka?oka, O. Rotkaja and L. Vara?eva, “Enantioseparation of 1-Phenyl-1,2,3,4-tetrahydroisoquinoline on Polysaccharide-Based Chiral Stationary Phases,” Chromatographia, Vol. 73, No. 1, 2011, pp. 123-129. 
doi:10.1007/s10337-011-1991-9 </mixed-citation></ref><ref id="scirp.29051-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">A. Lee, H. J. Choi, K. B. Jin and M. H. Hyun, “Liquid Chromatographic Resolution of 1-Aryl-1,2,3,4-Tetrahydroisoquinolines on a Chiral Stationary Phase Based on (+)-(18-Crown-6)-2,3,11,12-Tetracarboxylic Acid,” Journal of Chromatography A, Vol. 1218, No. 26, 2011, pp. 4071-4076. doi:10.1016/j.chroma.2011.04.088</mixed-citation></ref><ref id="scirp.29051-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">H. Inoue, D. Matsubara and Y. Tsuruta, “Simultaneous Analysis of 1,2,3,4-Tetrahydroisoquinolines by High-Performance Liquid Chromatography Using 4-(5,6-Dimethoxy-2-phthalimidinyl)-2-methoxyphenylsulfonyl Chloride as a Fluorescent Labeling Reagent,” Journal of Chromatography B, Vol. 867, No. 1, 2008, pp. 32-36. 
doi:10.1016/j.jchromb.2008.03.002</mixed-citation></ref><ref id="scirp.29051-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Y. Song, J. Xu, A. Hamme and Y.-M. Liu, “Capillary Liquid Chromatography-Tandem Mass Spectrometry of Tetrahydroisoquinoline Derived Neurotoxins: A Study on the Blood-Brain Barrier of Rat Brain,” Journal of Chromatography A, Vol. 1103, No. 2, 2006, pp. 229-234. 
doi:10.1016/j.chroma.2005.11.014</mixed-citation></ref><ref id="scirp.29051-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">M. Cai and Y.-M. Liu, “Quantification of Salsolinol Enantiomers by Stable Isotope Dilution Liquid Chromatography with Tandem Mass Spectrometric Detection,” Rapid Communications in Mass Spectrometry, Vol. 22, No. 24, 2008, pp. 4171-4177. doi:10.1002/rcm.3847</mixed-citation></ref><ref id="scirp.29051-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">N. R. Srinivas, W. C. Shyu and R. H. Barbhaiya, “Gas Chromatographic Determination of Enantiomers as Diastereomers Following Pre-Column Derivatization and Applications to Pharmacokinetic Studies: A Review,” Biomedical Chromatography, Vol. 9, No. 1, 1995, pp. 1-9. 
doi:10.1002/bmc.1130090102</mixed-citation></ref><ref id="scirp.29051-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">E. Gil-Av and D. Nurok, “Resolution of Optical Isomers by Gas Chromatography of Diastereomers,” In: J. C. Giddings and R. A. Keller, Eds., Advances in Chromatography, Marcel Dekker, New York, 1974, pp. 99-172.</mixed-citation></ref><ref id="scirp.29051-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">J. A. Dale, D. L. Dull and H. S. Mosher, “α-Methoxy-αtrifluoromethylphenylacetic Acid, a Versatile Reagent for the Determination of Enantiomeric Composition of Alcohols and Amines,” Journal of Organic Chemistry, Vol. 34, No. 9, 1969, pp. 2543-2549. 
doi:10.1021/jo01261a013</mixed-citation></ref><ref id="scirp.29051-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">F. Shimoma, H. Kusaka, K. Wada, H. Azami, M. Yasunami, T. Suzuki, H. Hagiwara and M. Ando, “A Novel Synthetic Method of the (±)-(3aα,8aα)-Ethyl 8β-Hydroxy6β-methyl-2-oxooctahydro-2H-cyclohepta[b]furan-3α-carboxylate and Its Chemical Transformation to (±)-(3aα, 8aα)-3α,6β-Dimethyl-3,3a,4,5,6,8a-hexahydro-2H-cyclohepta[b]furan-2-one, (+)and (?)-7β-(2-Acetoxy-1α-methylethyl)-4β-methyl-2-cyclohepten-1β-ol, and (+)and (?)-7β-(2-Acetoxy-1α-methylethyl)-4β-methyl-2-cyclohepten-1-one. Possible Common Synthetic Intermediates for Pseudoguaianolides, 4,5-Secopseudoguaianolides, Guaianolides, 4,5-Secoguaianolides, and Octalactins,” Journal of Organic Chemistry, Vol. 63, No. 4, 1998, pp. 920-929. 
doi:10.1021/jo971529q </mixed-citation></ref><ref id="scirp.29051-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">D. A. Allen, A. E. Tomaso Jr., O. P. Priest, D. F. Hindson and J. L. Hurlburt, “Mosher Amides: Determining the Absolute Stereochemistry of Optically-Active Amines,” Journal of Chemical Education, Vol. 85, No. 5, 2008, pp. 698-700. doi:10.1021/ed085p698</mixed-citation></ref><ref id="scirp.29051-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">C. Schotes and A. Mezzetti, “Asymmetric Diels-Alder Reactions of Unsaturated β-Ketoesters Catalyzed by Chiral Ruthenium PNNP Complexes,” Journal of American Chemical Society, Vol. 132, No. 11, 2010, pp. 3652-3653. 
doi:10.1021/ja910039e</mixed-citation></ref><ref id="scirp.29051-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">A. M. Gulamhussen, P. Ka?er, J. P?ech, M. Kuzma and L. ?erveny, “Highly Efficient Preparation of (R)-1-Methyltetrahydroisoquinoline Using Chiral Ru(II)-Catalyst,” Reaction Kinetics and Catalysis Letters, Vol. 97, No. 2, 2010, pp. 335-340. doi:10.1007/s11144-009-0036-y </mixed-citation></ref><ref id="scirp.29051-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">L. Chaoqun and X. Jianliang, “Asymmetric Hydrogenation of Cyclic Imines with an Ionic Cp*Rh(III) Catalyst,” Journal of American Chemical Society, Vol. 130, No. 40, 2008, pp. 13208-13209. doi:10.1021/ja8050958</mixed-citation></ref><ref id="scirp.29051-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">D. J. Ager, A. H. M. de Vries and J. G. de Vries, “Asymmetric Homogeneous Hydrogenations at Scale,” Chemical Society Reviews, Vol. 41, 2012, pp. 3340-3380. 
doi:10.1039/C2CS15312B</mixed-citation></ref></ref-list></back></article>